Elevated von Willebrand factor antigen predicts deterioration in diabetic peripheral nerve function

Diabetologia

Volumn 39, Issue 3, 1996, Pages 336-343

  Plater, M E ^a   Ford, I ^a   Dent, M T ^a   Preston, F E ^a   Ward, J D ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

Endothelial function; Peripheral neuropathy; Von Willebrand factor

Indexed keywords

MARKER; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEUROPATHY; ENDOTHELIUM INJURY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NERVE CONDUCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROSPECTIVE STUDY;

EID: 0030021520     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00418350     Document Type: Article

References (40)

1. Boulton AJM, Knight G, Drury J, Ward JD (1985) The prevalence of symptomatic diabetic neuropathy in an insulin treated population. Diabetes Care 8: 125-128
2. Ward JD (1982) The diabetic leg. Diabetologia 22: 141-147
3. Tesfaye S, Malik R, Ward JD (1994) Vascular factors in diabetic neuropathy. Diabetologia 37: 847-854
4. Jaffe EA, Hoyer LW, Nachman RL (1974) Synthesis of von Willebrand factor by cultured human endothelial cells. Proc Natl Acad Sci USA 71: 1906-1909
5. Suffredini AF, Harpel PC, Parrillo JE (1984) Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects. N Engl J Med 320: 1165-1172
6. Jansson JH, Nilsson TK, Johnson O (1991) Von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death. Br Heart J 66: 351-355
7. Boneu B, Abbal M, Plante J, Bierne R (1975) Factor VIII complex and endothelial cell damage. Lancet I:1430
8. Sakariassen KS, Bolhuis PA, Sixma JJ (1979) Human blood platelet adhesion to artery subendothelium mediated by factor VIII-von Willebrand factor bound to subendothelium. Nature 279: 63
9. Weiss HJ, Turitto VT, Baumgartner HR (1979) Effect of shear rate on platelet interaction with subendothelium in citrated and native blood. J Lab Clin Med 92: 750-764
10. Ruggeri ZM, Ware J (1992) The structure and function of von Willebrand Factor. Thromb Haemostas 67: 594-599
11. Porta M, Kohner E, Molinatti G (1987) In vivo studies of endothelial cell function in diabetic microangiopathy. Front Diabetes 8: 16-28
12. Bensoussan D, Levy-Toledano S, Passa P, Caen J, Canivet J (1975) Platelet hyperaggregation and increased plasma von Willebrand factor in diabetes with retinopathy. Diabetologia 11: 307-312
13. 1a-c. Studies in diabetic patients and normal persons. Ann Int Med 88: 314-316
14. Jensen T (1989) Increased plasma concentration of von Willebrand factor in type 1 (insulin dependent) diabetic patients with incipient nephropathy. BMJ 298: 27-28
15. Stehouwer CDA, Stroes ESG, Hackeng WHL, Mulder PGH, den Ottolander GJH (1991) Von Willebrand factor and development of diabetic nephropathy in insulin dependent diabetes mellitus. Diabetes 40: 971-976
16. Jensen T, Bjerre-Knudsen J, Feldt-Rasmussen B, Decken T (1989) Features of endothelial dysfunction in early diabetic nephropathy. Lancet I:461-463
17. Porta M, Maneschi F, White MC, Kohner EM (1981) Twenty four hour variation of von Willebrand factor and factor VIII related antigen in diabetic retinopathy. Metabolism 30: 695-699
18. Borkenstein MH, Muntean WE (1982) Elevated factor VIII activity and factor VIII related antigen in diabetic children without vascular disease. Diabetes 31: 1006-1009
19. Muntean WE, Borkenstein MH, Haas J (1985) Elevation of factor VIII coagulant activity over factor VIII coagulant antigen in diabetic children without vascular disease. Diabetes 34: 140-144
20. Rak K, Beck P, Udvardy M et al. (1983) Plasma levels of beta thromboglobulin and factor VIII related antigen in diabetic children and adults. Thromb Res 29: 155-162
21. Paton RC, Passa PL, Canivet J (1981) Von Willebrand factor, diabetes mellitus and retinopathy. Horm Metab Res Suppl 11: 55-58
22. Gensini GF, Abbate R, Favilla S, Neri Serneri G (1979) Changes in platelet function and blood clotting in diabetes mellitus. Thromb Haemost 42: 983-993
23. Christe M, Fritschi J, Lammle B et al. (1984) Fifteen coagulation and fibrinolysis parameters in diabetes mellitus and in patients with vasculopathy. Thromb Haemost 52: 138-143
24. Van Oost BA, Veldhuyzen BFE, Van Houweungen HC, Timmermans APM, Sixma JJ (1982) Tests for platelet changes, acute phase reactants and serum lipids in diabetes and peripheral vascular disease. Thromb Haemost 48: 289-293
25. Yao ST, Hobbs JT, Irvine WT (1969) Ankle systolic measurements in arterial disease affecting the lower extremities. Br J Surg 56: 676-679
26. EDTRS Coordinating Centre (1980) Manual of operations, chapters 5, 8. Diabetic Retinopathy Study Coordinating centre, Baltimore
27. Evans RJ, Austen DEG (1977) Assay of ristocetin cofactor using fixed platelets and a platelet counting technique. Br J Haematol 37: 289-294
28. Blann AD (1995) Annotation. A reliable marker of endothelial cell dysfunction: does it exist? Br J Haematol 90: 244-248
29. Thomas PK, Ward JD (1991) Diabetic neuropathy: epidemiology and pathogenesis; and clinical aspects of diabetic somatic neuropathy. In: Pickup JC, Williams G (eds) Textbook of diabetes, vol 2. Blackwell, Oxford London Edinburgh Boston Melbourne Paris Berlin Vienna, pp 613-634
30. Fagerberg SE (1959) Diabetic neuropathy: a clinical and histological study on the significance of vascular affections. Acta Med Scand 164 [Suppl 345]: 5-81
31. Malik RA, Tesfaye S, Thompson SD et al. (1993) Endoneurial localisation of microvascular damage in human diabetic neuropathy. Diabetologia 36: 454-459
32. Newrick PG, Wilson AJ, Jakubowski J, Boulton AJM, Ward JD (1986) Sural nerve oxygen tension in diabetes. BMJ 293: 1053-1054
33. Ford I, Malik RA, Newrick PG et al. (1992) Relationships between haemostatic factors and capillary morphology in human diabetic neuropathy. Thromb Haemost 68: 628-633
34. Stehouwer CDA, Nauta JJP, Zeldenrust GC et al. (1992) Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet 340: 319-323
35. Stehouwer CDA, Zellenrath P, Polak BCP et al. (1992) Von Willebrand factor and early diabetic retinopathy: no evidence for a relationship in patients with type 1 (insulin-dependent) diabetes mellitus and normal urinary albumin excretion. Diabetologia 35: 555-559
36. Tesfaye ST, Stevens L, Stephenson J, Ward JD on behalf of the EURODIAB IDDM study group (1993) The prevalence of diabetic neuropathy and its relation to glycaemic control in insulin-dependent subjects in Europe. Diabetologia 36 [Suppl 1]: 176 (Abstract)
37. Stehouwer CDA, Andreas Fischer HR, vanKuijk AWR, Polak BCP, Donker AJM (1995) Endothelial dysfunction precedes development of microalbuminuria in IDDM. Diabetes 44: 561-564
38. Ward JD, Barnes CG, Fisher DJ, Barker RWR (1971) Improvement in nerve conduction following treatment in newly diagnosed diabetics. Lancet 1: 428-431
39. Vukovich TC, Schernthaner G, Knobi PN, Hay U (1989) The effect of near normoglycemic control on plasma factor VIII/von Willebrand factor and fibrin degradation products in insulin dependent diabetic patients. J Clin Endocrinol Metab 69: 84-89
40. Dyck PJ (1988) Detection, characterization, and staging of polyneuropathy: assessed in diabetics. Muscle Nerve 11: 21-32